Crinetics Pharmaceuticals Inc (CRNX)
R&D Expenses
$99.85M
Quarterly · Period ending: · USD
CRNX R&D Expenses
Latest reported$99.85Mperiod ending
Latest reported$99.85Mperiod ending
CRNX Quarterly R&D Expenses ($2.07M → $99.85M)
Quarterly R&D Expenses
High-resolution chart · PNG
CRNX r&d expenses history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D Expenses (USD) |
|---|---|
| 99,850,000 | |
| 100,081,000 | |
| 85,053,000 | |
| 90,464,000 | |
| 80,301,000 | |
| 76,240,000 | |
| 66,566,000 | |
| 61,905,000 | |
| 58,344,000 | |
| 53,341,000 | |
| 45,623,000 | |
| 43,839,000 | |
| 40,640,000 | |
| 38,468,000 | |
| 36,991,000 | |
| 31,987,000 | |
| 32,995,000 | |
| 28,252,000 | |
| 24,604,000 | |
| 21,680,000 | |
| 20,687,000 | |
| 17,639,000 | |
| 16,830,000 | |
| 13,699,000 | |
| 12,607,000 | |
| 13,862,000 | |
| 12,143,000 | |
| 11,823,000 | |
| 10,285,000 | |
| 7,255,000 | |
| 7,651,000 | |
| 6,886,000 | |
| 5,222,000 | |
| 4,720,000 | |
| 2,562,000 | |
| 2,523,000 | |
| 2,083,000 | |
| 2,065,000 |